Chris Holland

Company: Immunocore Ltd

Job title: Senior Manager, Research

Seminars:

Expanding the ImmTAX Platform to Gamma Delta T Cell Targets 11:45 am

Introduction to the Immunocore ImmTAX platform and the first approved TCR bi-specific therapeutic. Establishment of a γδ TCR discovery platform Development of an affinity enhanced γδ TCRRead more

day: Conference Day One - Track B